Patent · US Active

Systems, compositions and methods for treating diabetes

US11357829B2 · kind B2 · utility

0Cited by
5References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 2, 2018
Grant dateJun 14, 2022
Priority date—
Expiry dateFeb 25, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2300/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure provides methods for treatment comprising co-administering insulin and glucagon to a subject, and co-formulations comprising insulin and glucagon.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.